XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$37.74
-1.45 (-3.70%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Price Target
Analyst Price Target
-47.1% upside
Low Target
$12.55
Average Target
$19.98
High Target
$22.13
Current Price
$37.74
Current
$37.74
$37.74
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Scenario Analysis
Bear Case
$12.55
-66.7%
Low target
Base Case
$19.98
-47.1%
Avg target
Bull Case
$22.13
+-41.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$72.66
-48.1% from high
52-Week Low
$33.38
+13.1% from low
50-Day SMA
$44.01
-14.2% vs SMA
200-Day SMA
$52.33
-27.9% vs SMA
RSI (14)
74.9
Overbought
Target vs 52W High
$19.98
-72.5% vs high
Next Earnings Report
Nov 11, 2026 · After Market Close
4d
until earnings
EPS Est: $-1.16
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |